All Stories

  1. High-Dose Semaglutide (Up to 16 mg) in People With Type 2 Diabetes and Overweight or Obesity: A Randomized, Placebo-Controlled, Phase 2 Trial

    Article • Diabetes Care, April 2025, American Diabetes Association

    vanita aroda

  2. Management of type 2 diabetes with the first oral GLP-1RA, oral semaglutide

    Article • Diabetes Care, June 2019, American Diabetes Association

    vanita aroda